The Alere i Influenza A & B 2 test has received 510(k) marketing clearance from the US FDA for the detection of influenza A and B infection in children and adults, according to Alere Inc. The approval comes just days before the closure of Abbott Diagnostics’ acquisition of Alere, which…
Source: RT
Read more: FDA Green-lights Alere i Influenza A & B 2 Diagnostic